Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PASylated VEGFR/PDGFR fusion proteins and their use in therapy

PASylated VEGFR/PDGFR fusion proteins and their use in therapy

US Patent 11548931 · Granted Jan 10, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted pyridines as PARP1 inhibitors2025
Modulators of TNF alpha activity and uses thereof2025
PARP1 inhibitors and uses thereof2025
Thyroid hormone receptor agonists and uses thereof2025
Substituted 1,2,4-triazoles as TYK2 inhibitors2025
Pyridinone MK2 inhibitors and uses thereof2024
Substituted 1,2,4-triazoles as intermediates in the synthesis of TYK2 inhibitors2024
Substituted pyridazines as TYK2 inhibitors2024
Substituted pyridines as PARP1 inhibitors2024
MK2 inhibitors and uses thereof2024
Thyroid hormone receptor agonists and uses thereof2024
PARP1 inhibitors and uses thereof2024